CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale Director sold 13,973 shares at an average $80.66 ($1,127,120)
- 4 Open-market sale SVP, HEAD - ESTABLISHED BRANDS sold 459 shares at $79.21 ($36,357)
- 4 Open-market sale PRESIDENT & CEO sold 55,000 shares at $77.57 ($4,266,350)
- 4 Open-market sale SVP, GENERICS sold 2,772 shares at $79.50 ($220,374)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $78.16 ($39,080)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $77.95 ($38,975)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Auditor change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 3 of 90 · 1,784 filings